News
M&A deals announced worldwide in July included a rail merger, which is the largest transaction in the past 12 months based on ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
MSD's plan to reduce its headcount by around 6,000, first revealed a couple of weeks ago, looks like it will start at its ...
2d
Zacks Investment Research on MSNMerck's Narrowed 2025 Sales View: What it Means After Q2 Results?
Merck MRK announced mixed second-quarter results last month. The company beat estimates for earnings while meeting the same ...
6d
Zacks Investment Research on MSNInvestors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Merck (MRK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts ...
Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...
Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently talked about. Cramer mentioned the stock and said that ...
Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for ...
Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...
The multiyear effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster ...
IO Biotech said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's ...
Merck & Co., Inc. (NYSE:MRK) will release earnings results for the second quarter before the opening bell on Tuesday, July 29 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results